Ascension PyroCarbon Radial Head Study (CMRH)

Safety and Effectiveness Study of Ascension PyroCarbon Radial Head Compared to Ascension Metal Radial Head

The proportion of patient successes with the Carbon Modular Radial Head at the 2-year evaluation is no lower than the proportion of patient successes with the Metal Radial Head.

Study Overview

• Status: Terminated
• Conditions: Rheumatoid Arthritis; Degenerative Arthritis; Radial Head Fracture
• Intervention / Treatment: Device: Carbon Modular Radial Head replacement; Device: Metal Radial Head replacement

Detailed Description

This investigation will include 179 patients (119 study devices and 60 control devices) enrolled at 15 active centers. In addition a subset of 24 RA patients will be enrolled and analyzed separately. The trial is designed as a randomized, non-inferiority study comparing results of the CMRH to results of the MRH.

This will be a multi-site study with all patients either receiving the CMRH or the MRH. Sequential enrollment of all patients meeting inclusion criteria and agreeing to be in the study will be enrolled. The patients will sign an informed consent agreeing to accept either the investigational or control device. In addition, the surgeon will not know which device the patient is to receive until the day of surgery in an attempt to further reduce bias. The surgeon will open an envelope at the time of surgery to determine if a CMRH or MRH will be implanted.

Additional efforts to eliminate bias in the study will include a final radiographic analysis by an independent observer experienced in reporting on orthopedic devices. The independent reviewer will grade the surgical implant and determine radiographic success/failure for each patient.

Implants will be assigned to patients at the clinical sites in a block randomization fashion. The randomization will be site specific. At a given site, each consecutive block of six enrolled patients to be treated will receive random assignments of CMRH or MRH at a 2:1. The randomization schedule is generated by computer (NQuery) and is produced in blocks of 6, where 4 are study devices and 2 are control devices.

• Study Type: Interventional
• Enrollment (Actual): 78
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Florida
    • Gainesville, Florida, United States, 32611
      • University of Florida Orthopedic and Rehabilitation
  • Ohio
    • Dayton, Ohio, United States, 45405
      • Hand Center of Southwestern Ohio
  • Pennsylvania
    • Philadelphia, Pennsylvania, United States, 19107
      • The Rothman Institute
  • Texas
    • Houston, Texas, United States, 77030
      • Texas Orthopedic Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 85 years (ADULT, OLDER_ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Patients must need a radial head replacement for:

  • Degenerative, post-traumatic or rheumatoid arthritis
  • Primary replacement after fracture of the radial head
  • Relief of symptoms after radial head resection
  • Revision of failed radial head arthroplasty
  • Skeletally mature individuals ages 18 - 85

Exclusion Criteria:

• Inadequate bone stock or soft tissue coverage
• Previous open fracture or infection in the joint
• Individuals under age of 18 or over 85 years of age
• Physical interference with or by other prostheses during implantation or use
• Procedures requiring modification of the prosthesis
• Skin, bone, circulatory and/or neurological deficiency at the implantation site
• Prisoners
• Patients on chronic corticosteroid or non-steroidal anti-inflammatory therapy

Study Plan

How is the study designed?

Design Details

• Primary Purpose: TREATMENT
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: DOUBLE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Carbon Modular Radial Head; PyroCarbon Modular Radial Head replacement	Device: Carbon Modular Radial Head replacement; 'Carbon Modular Radial Head replacement: The Ascension Radial Head is made of pyrocarbon, a material that testing has shown to be both wear resistant and biocompatible and has been used in surgical implants for years. The introduction of the pyrocarbon head should alleviate the problems associated with wear debris and fragmentation experienced with the silicone radial spacer.; Other Names: Ascension CMRH
ACTIVE_COMPARATOR: Metal Radial Head; Metal Radial Head replacement	Device: Metal Radial Head replacement; Metal Radial Head replacement:The Ascension® Modular Radial Head (MRH) is an anatomically designed, single-use, modular prosthesis designed for replacement of the proximal end of the radius. FDA cleared this device for commercial distribution under 510(k) K032686. It is made from medical grade cobalt chromium alloy meeting ASTM F1537. Head components are available in six sizes and stem components are available in four sizes are interchangeable and assembled with a taper connection.; Other Names: Ascension MRH

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Time Frame
The proportion of patient successes with the Carbon Modular Radial Head vs patient successes with the Metal Radial Head as assessed by implant survival	2 years

Collaborators and Investigators

• Sponsor: Smith & Nephew, Inc.
• Investigators: Study Director: Andrew Tummon, Integra Life Sciences

Study record dates

Study Major Dates

• Study Start: January 1, 2009
• Primary Completion (ACTUAL): March 1, 2015
• Study Completion (ACTUAL): January 1, 2017

Study Registration Dates

• First Submitted: November 4, 2014
• First Submitted That Met QC Criteria: March 27, 2015
• First Posted (ESTIMATE): April 1, 2015

Study Record Updates

• Last Update Posted (ACTUAL): August 11, 2022
• Last Update Submitted That Met QC Criteria: August 9, 2022
• Last Verified: August 1, 2017

More Information

Terms related to this study

• Keywords: Radial Head Arthroplasty
• Additional Relevant MeSH Terms: Joint Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Arthritis; Osteoarthritis
• Other Study ID Numbers: CP-RH-002

Drug and device information, study documents

• Studies a U.S. FDA-regulated device product: Yes